Answer
Yes, enfortumab vedotin can cause hair loss (alopecia), which is listed as a very common adverse reaction both when used alone and in combination with pembrolizumab.
Sources for this answer
- Padcev 20 mg and 30 mg powder for concentrate for solution for infusionAstellas Pharma Ltd · emc · SmPC §4.8 Undesirable effects · Version 10Document updated
Sources checked